Isomorphic Labs raised $5 billion to expand its AI drug-design work and advance drug candidates toward clinical trials, with Greenoaks and Sequoia leading the Series C and Alphabet investing again.

Published
Isomorphic Labs ↗ · Source dated
—

Published
Isomorphic Labs ↗ · Source dated
OpenAI chief scientist Jakub Pachocki wants rival labs to agree on when to pause AI training.
Treasury Secretary Questions Jensen Huang's Role Amid Compliance Inquiry
China plans standards for how AI providers count tokens, bill customers and measure service quality, National Data Administration chief Liu Liehong said Nov.
Tesla's AI4 Computer Cost Doubles Due to Memory Price Hikes
Checking account…
Loading comments…